Health Care

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn't have insurance coverage for the treatments. 

Merck said the expected tariff charge primarily reflects levies between the U.S. and China, but does not account for Trump's planned pharmaceutical tariffs.

Shares of Bristol Myers Squibb fell modestly after the drugmaker's better-than-expected first-quarter results.

The guidance revisions include the estimated impact of current tariffs on U.S. products shipped to China, but not Trump's planned pharmaceutical tariffs.

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro.

The FDA is phasing out the use of petroleum-based synthetic dyes in food and drinks.

Trump proposed a change to Medicare price talks that has long been sought after by the pharmaceutical industry.

Count us among the Danaher investors breathing a sigh of relief.

First-quarter earnings season picks up speed inside our portfolio and outside of it.

The warning sign from a health-care giant seen as the insurance industry's bellwether may mean trouble for companies with Medicare Advantage plans.